Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Docetaxel With a Phytochemical in Treating Patients With Hormone Independent Metastatic Prostate Cancer (PROTAXY)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Philippe Chollet, Centre Jean Perrin
ClinicalTrials.gov Identifier:
NCT01012141
First received: November 10, 2009
Last updated: April 9, 2013
Last verified: November 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2011
  Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)